Heart and Mind Trial
Cross-source consensus on Heart and Mind Trial from 1 sources and 5 claims.
1 sources · 5 claims
Where it comes from
Other
Other
Other
Highlighted claims
- The study used initial screening data from the Heart and Mind randomised clinical trial. — Prevalence and types of anxiety disorders among patients with cardiac conditions and elevated HADS-A scores: findings from the initial screening phase of the Heart and Mind trial in Denmark
- Patients were screened between May 2021 and May 2023 at four Danish hospital sites. — Prevalence and types of anxiety disorders among patients with cardiac conditions and elevated HADS-A scores: findings from the initial screening phase of the Heart and Mind trial in Denmark
- Eligible patients had a primary diagnosis of arrhythmia, heart failure, or ischaemic heart disease. — Prevalence and types of anxiety disorders among patients with cardiac conditions and elevated HADS-A scores: findings from the initial screening phase of the Heart and Mind trial in Denmark
- The parent trial required HADS-A to exceed HADS-D because it tested an anxiety-focused intervention. — Prevalence and types of anxiety disorders among patients with cardiac conditions and elevated HADS-A scores: findings from the initial screening phase of the Heart and Mind trial in Denmark
- The broader trial randomised patients with cardiac conditions and a confirmed anxiety or adjustment disorder to cognitive behavioural therapy or usual care. — Prevalence and types of anxiety disorders among patients with cardiac conditions and elevated HADS-A scores: findings from the initial screening phase of the Heart and Mind trial in Denmark